The company is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on pruritus.
Read More
The presentation is expected to cover the company’s strategic business activities, financial and operational performance, and outlook for the future.
Read More
The subject of the panel discussion will be Impact Investing: Medical Efficacy and Societal Impact of Legal Cannabis.
Read More
These include the 2019 Canaccord Cannabis Conference, to be held May 14, 2019 and the BMO 14th Annual Farm to Market Conference to be held May 15-16, 2019.
Read More
Get stock alerts, news & related alerts straight to your inbox!